首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Fc varepsilon RI-FcgammaRII Coaggregation inhibits IL-16 production from human langerhans-like dendritic cells.
【24h】

Fc varepsilon RI-FcgammaRII Coaggregation inhibits IL-16 production from human langerhans-like dendritic cells.

机译:Fc varepsilon RI-FcgammaRII共聚集可抑制人类兰氏样树突状细胞产生IL-16。

获取原文
获取原文并翻译 | 示例
           

摘要

Langerhans-like dendritic cells (LLDC) express the high-affinity IgE receptor Fc varepsilon RI form that lacks the beta-chain, and may play an important role in allergic inflammation via production of IL-16. Secretion of mediators by human mast cells and basophils is mediated through Fc varepsilon RI and is decreased by coaggregating these receptors to the low-affinity IgG receptor, FcgammaRII. We used a recently described human Ig fusion protein (GE2), which is composed of key portions of the human gamma1 and the human varepsilon heavy chains, to investigate its ability to inhibit IL-16 production from Fc varepsilon RI-positive Langerhans-like dendritic cells through coaggregation of FcgammaRII and Fc varepsilon RI. Unstimulated LLDC-derived from CD14-positive monocytes from atopic donors were shown to express FcgammaRII, an ITIM-containing receptor, but not Fc varepsilon RI or FcgammaRIII which are activating (ITAM) receptors. When passively sensitized with antigen-specific, human IgE and then challenged with antigen, LLDC were stimulated to produce IL-16. However, when Fc varepsilon RI and FcgammaRII were coaggregated with GE2, IL-16 production was significantly inhibited. Exposure of LLDCs to GE2 alone did not induce IL-16 production. Our results further extend our studies demonstrating the ability of GE2 to inhibit Fc varepsilon RI-mediated responses through coaggregation with FcgammaRIIB and at the same time show that human LDCC can be modulated in a fashion similar to mast cells and basophils.
机译:朗格汉斯样树突状细胞(LLDC)表达缺乏β链的高亲和力IgE受体Fc缬氨酸RI形式,并可能通过产生IL-16在过敏性炎症中发挥重要作用。人肥大细胞和嗜碱性粒细胞的介体分泌是通过Fc varepsilon RI介导的,并且通过将这些受体聚集到低亲和力IgG受体FcgammaRII上而减少。我们使用了一种最近描述的人Ig融合蛋白(GE2),该蛋白由人gamma1和人varepsilon重链的关键部分组成,来研究其抑制Fc varepsilon RI阳性朗格汉斯样树突状细胞抑制IL-16产生的能力。 FcγRII和Fc varepsilon RI的共聚集作用。显示来自特应性供体的CD14阳性单核细胞的未经刺激的LLDC表达FcgammaRII(一种含ITIM的受体),但不表达激活性(ITAM)受体的Fc varepsilon RI或FcgammaRIII。当用抗原特异性人类IgE被动敏化,然后用抗原攻击时,刺激LLDC产生IL-16。但是,当Fc varepsilon RI和FcγRII与GE2共同聚集时,IL-16的产生被显着抑制。仅将LLDC暴露于GE2不会诱导IL-16产生。我们的结果进一步扩展了我们的研究,证明了GE2通过与FcgammaRIIB的共聚集抑制Fc varepsilon RI介导的反应的能力,同时表明,可以以类似于肥大细胞和嗜碱性粒细胞的方式调节人LDCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号